Social support is associated with reduced stigma and shame in a sample of rural and small urban adults in methadone treatment

References

• Aghakhani N, Lopez V, Cleary M. 2017. Experiences and perceived social support among Iranian men on methadone maintenance therapy: a qualitative study. Issues Ment Health Nurs. 38(9):692–697.
   PubMed Web of Science ®Google Scholar
• Andraka-Christou B, Nguyen T, Harris S, Madeira J, Totaram R, Randall-Kosich O, Atkins D, Ford J. 2020. College students’ perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities. Am J Drug Alcohol Abuse. 46(5):589–603.
   PubMed Web of Science ®Google Scholar
• Andrews B, Qian M, Valentine JD. 2002. Predicting depressive symptoms with a new measure of shame: the experience of shame scale. Br J Clin Psychol. 41(Pt 1):29–42.
   PubMedGoogle Scholar
• Ashford RD, Lynch K, Curtis B. 2018. Technology and social media use among patients enrolled in outpatient addiction treatment programs: cross-sectional survey study. J Med Internet Res. 20(3):e9172.
   Web of Science ®Google Scholar
• Best D, Beckwith M, Haslam C, Alexander Haslam S, Jetten J, Mawson E, Lubman DI. 2016. Overcoming alcohol and other drug addiction as a process of social identity transition: the social identity model of recovery (SIMOR). Addict Res Theory. 24(2):111–123.
   Web of Science ®Google Scholar
• Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, Mimiaga MJ, Saitz R, Bazzi AR. 2019. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 198:80–86.
   PubMed Web of Science ®Google Scholar
• Brener L, Von Hippel W, Von Hippel C, Resnick I, Treloar C. 2010. Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach. Drug Alcohol Rev. 29(5):491–497.
   PubMed Web of Science ®Google Scholar
• Brousseau NM, Farmer H, Karpyn A, Laurenceau JP, Kelly JF, Hill EC, Earnshaw VA. 2022. Qualitative characterizations of misinformed disclosure reactions to medications for opioid use disorders and their consequences. J Subst Abuse Treat. 132:108593.
   PubMed Web of Science ®Google Scholar
• Brown SA. 2015. Stigma towards marijuana users and heroin users. J Psychoactive Drugs. 47(3):213–220.
   PubMed Web of Science ®Google Scholar
• Brown S, Tracy EM, Jun M, Park H, Min MO. 2015. Personal network recovery enablers and relapse risks for women with substance dependence. Qual Health Res. 25(3):371–385.
   PubMed Web of Science ®Google Scholar
• Calcaterra SL, Bach P, Chadi A, Chadi N, Kimmel SD, Morford KL, Roy P, Samet JH. 2019. Methadone matters: what the United States can learn from the global effort to treat opioid addiction. J Gen Intern Med. 34(6):1039–1042.
   PubMed Web of Science ®Google Scholar
• Chang C-C, Chang K-C, Hou W-L, Yen C-F, Lin C-Y, Potenza MN. 2020. Measurement invariance and psychometric properties of perceived stigma toward people who use substances (PSPS) among three types of substance use disorders: heroin, amphetamine, and alcohol. Drug Alcohol Depend. 216:108319.
   PubMed Web of Science ®Google Scholar
• Chang C-W, Chang K-C, Griffiths MD, Chang C-C, Lin C-Y, Pakpour AH. 2022. The mediating role of perceived social support in the relationship between perceived stigma and depression among individuals diagnosed with substance use disorders. J Psychiatr Ment Health Nurs. 29(2):307–316.
   PubMed Web of Science ®Google Scholar
• Cooper S, Nielsen S. 2017. Stigma and social support in pharmaceutical opioid treatment populations: a scoping review. Int J Ment Health Addict. 15(2):452–469.
   Web of Science ®Google Scholar
• D'Aunno T, Park S, Pollack HA. 2019. Evidence-based treatment for opioid use disorders: a national study of methadone dose levels, 2011–2017. J Subst Abuse Treat. 96:18–22.
   PubMed Web of Science ®Google Scholar
• Day E, Copello A, Karia M, Roche J, Grewal P, George S, Haque S, Chohan G. 2013. Social network support for individuals receiving opiate substitution treatment and its association with treatment progress. Eur Addict Res. 19(4):211–221.
   PubMed Web of Science ®Google Scholar
• Dyregrov K, Selseng LB. 2022. "Nothing to mourn, he was just a drug addict" - stigma towards people bereaved by drug-related death. Addict Res Theory. 30(1):5–15.
   Web of Science ®Google Scholar
• Earnshaw VA, Bogart LM, Menino D, Kelly JF, Chaudoir SR, Brousseau N, Levy S. 2019. Disclosure, stigma, and social support among young people receiving treatment for substance use disorders and their caregivers: a qualitative analysis. Int J Ment Health Addict. 17(6):1535–1549.
   PubMed Web of Science ®Google Scholar
• Earnshaw VA, Sepucha KR, Laurenceau JP, Subramanian SV, Brousseau NM, Chaudoir SR, Hill EC, Morrison LM, Kelly JF. 2021. Disclosure processes as predictors of relationship outcomes among people in recovery from opioid use disorder: a longitudinal analysis. Drug Alcohol Depend. 228:109093.
   PubMed Web of Science ®Google Scholar
• Earnshaw V, Smith L, Copenhaver M. 2013. Drug addiction stigma in the context of methadone maintenance therapy: an investigation into understudied sources of stigma. Int J Ment Health Addict. 11(1):110–122.
   PubMed Web of Science ®Google Scholar
• Enders CK. 2006. A primer on the use of modern missing-data methods in psychosomatic medicine research. Psychosom Med. 68(3):427–436.
   PubMed Web of Science ®Google Scholar
• Feng N, Lin C, Hsieh J, Rou K, Li L. 2018. Family related factors and concurrent heroin use in methadone maintenance treatment in China. Subst Use Misuse. 53(10):1674–1680.
   PubMed Web of Science ®Google Scholar
• Fuhrer R, Stansfeld SA, Chemali J, Shipley MJ. 1999. Gender, social relations and mental health: prospective findings from an occupational cohort (Whitehall II study). Soc Sci Med. 48(1):77–87.
   PubMed Web of Science ®Google Scholar
• Garcia-Portilla MP, Bobes-Bascaran MT, Bascaran MT, Saiz PA, Bobes J. 2014. Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack? Br J Clin Pharmacol. 77(2):272–284.
   PubMed Web of Science ®Google Scholar
• Goodyear K, Chavanne D. 2021. Stigma and policy preference toward individuals who transition from prescription opioids to heroin. Addict Behav. 115:106784.
   PubMed Web of Science ®Google Scholar
• Haffajee RL, Bohnert AS, Lagisetty PA. 2018. Policy pathways to address provider workforce barriers to buprenorphine treatment. Am J Prev Med. 54(6 Suppl 3):S230–S242.
   PubMed Web of Science ®Google Scholar
• Haylock PAC, Carter A, Savic M, Lubman DI. 2022. Regional and rural clients’ presenting concerns and experiences of care when engaging with an online substance use counseling service. Addict Res Theory. https://doi.org/10.1080/16066359.2022.2039911.
   Google Scholar
• Hojjat SK, Rezaei M, Hatami SE, Kohestani M, Norozi Khalili M. 2017. The effectiveness of group family training about the principles of harm reduction approach on marital satisfaction of spouses of patients under methadone maintenance treatment. J Sex Marital Ther. 43(1):68–77.
   PubMed Web of Science ®Google Scholar
• Humphreys K, Mankowski ES, Moos RH, Finney JW. 1999. Do enhanced friendship networks and active coping mediate the effect of self-help groups on substance abuse? Ann Behav Med. 21(1):54–60.
   PubMed Web of Science ®Google Scholar
• Janulis P, Ferrari JR, Fowler P. 2013. Understanding public stigma toward substance dependence: public stigma toward dependence. J Appl Soc Psychol. 43(5):1065–1072.
   Web of Science ®Google Scholar
• Kelly JF, Greene MC, Abry A. 2021. A US national randomized study to guide how best to reduce stigma when describing drug-related impairment in practice and policy. Addiction. 116(7):1757–1767.
   PubMed Web of Science ®Google Scholar
• Kelly SM, O'Grady KE, Schwartz RP, Peterson JA, Wilson ME, Brown BS. 2010. The relationship of social support to treatment entry and engagement: the community assessment inventory. Subst Abus. 31(1):43–52.
   PubMed Web of Science ®Google Scholar
• Keyes KM, Hatzenbuehler ML, McLaughlin KA, Link B, Olfson M, Grant BF, Hasin D. 2010. Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol. 172(12):1364–1372.
   PubMed Web of Science ®Google Scholar
• Kidorf M, Brooner RK, King VL. 1997. Motivating methadone patients to include drug-free significant others in treatment: a behavioral intervention. J Subst Abuse Treat. 14(1):23–28.
   PubMed Web of Science ®Google Scholar
• Kidorf M, King V, Neufeld K, Stoller K, Peirce J, Brooner R. 2005. Involving significant others in the care of opioid-dependent patients receiving methadone. J Subst Abuse Treat. 29(1):19–27.
   PubMed Web of Science ®Google Scholar
• Kilian C, Manthey J, Carr S, Hanschmidt F, Rehm J, Speerforck S, Schomerus G. 2021. Stigmatization of people with alcohol use disorders: an updated systematic review of population studies. Alcohol Clin Exp Res. 45(5):899–911.
   PubMed Web of Science ®Google Scholar
• Koehl JL, Zimmerman DE, Bridgeman PJ. 2019. Medications for management of opioid use disorder. Am J Health Syst Pharm. 76(15):1097–1103.
   PubMed Web of Science ®Google Scholar
• Krawczyk N, Negron T, Nieto M, Agus D, Fingerhood MI. 2018. Overcoming medication stigma in peer recovery: a new paradigm. Subst Abus. 39(4):404–409.
   PubMed Web of Science ®Google Scholar
• Lagory M, Ritchey F, Sells T. 1997. Gender differences in social support: mental health consequences among the homeless. Sociological Focus. 30(3):209–225.
   Google Scholar
• Laudet AB, Magura S, Vogel HS, Knight E. 2000. Addictions services: support, mutual aid and recovery from dual diagnosis. Community Ment Health J. 36(5):457–476.
   PubMed Web of Science ®Google Scholar
• Lin C, Wu Z, Detels R. 2011. Family support, quality of life and concurrent substance use among methadone maintenance therapy clients in China. Public Health. 125(5):269–274.
   PubMed Web of Science ®Google Scholar
• Link BG, Phelan JC. 2001. Conceptualizing stigma. Annu Rev Sociol. 27(1):363–385.
   Web of Science ®Google Scholar
• Lister JJ, Weaver A, Ellis JD, Himle JA, Ledgerwood DM. 2020. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. Am J Drug Alcohol Abuse. 46(3):273–288.
   PubMed Web of Science ®Google Scholar
• Madden EF. 2019. Intervention stigma: how medication-assisted treatment marginalizes patients and providers. Soc Sci Med. 232:324–331.
   PubMed Web of Science ®Google Scholar
• Mak WWS, Chan RCH, Wong SYS, Lau JTF, Tang WK, Tang AKL, Chiang TP, Cheng SKW, Chan F, Cheung FM, et al. 2017. A cross-diagnostic investigation of the differential impact of discrimination on clinical and personal recovery. Psychiatr Serv. 68(2):159–166.
   PubMed Web of Science ®Google Scholar
• Masson CL, Chen IQ, Levine JA, Shopshire MS, Sorensen JL. 2019. Health-related internet use among opioid treatment patients. Addict Behav Rep. 9:100157.
   PubMedGoogle Scholar
• Maurage P, Joassin F, Philippot P, Heeren A, Vermeulen N, Mahau P, Delperdange C, Corneille O, Luminet O, De Timary P. 2012. Disrupted regulation of social exclusion in alcohol-dependence: an fMRI study. Neuropsychopharmacology. 37(9):2067–2075.
   PubMed Web of Science ®Google Scholar
• Mushtaq S, Mendes V, Nikolaou V, Luty J. 2015. Analysis of the possible components of stigmatised attitudes towards depression and heroin dependence. J Substance Use. 20(6):399–406.
   Web of Science ®Google Scholar
• Nieweglowski K, Corrigan PW, Tyas T, Tooley A, Dubke R, Lara J, Washington L, Sayer J, Sheehan L. 2018. Exploring the public stigma of substance use disorder through community-based participatory research. Addict Res Theory. 26(4):323–329.
   Web of Science ®Google Scholar
• Palombi LC, Irish A, Bowen EA, Kosobuski L, Chen NS-Y, Hawthorne AN, Becher E. 2022. 'That’s got me to where I am today': examining the role of social capital in rural recovery. Addict Res Theory. 30(4):268–211.
   Web of Science ®Google Scholar
• Pattyn E, Verhaeghe M, Sercu C, Bracke P. 2014. Public stigma and self-stigma: differential association with attitudes toward formal and informal help seeking. Psychiatr Serv. 65(2):232–238.
   PubMed Web of Science ®Google Scholar
• Peckover S, Chidlaw RG. 2007. Too frightened to care? Accounts by district nurses working with clients who misuse substances. Health Soc Care Community. 15(3):238–245.
   PubMed Web of Science ®Google Scholar
• Polonsky M, Azbel L, Wickersham JA, Taxman FS, Grishaev E, Dvoryak S, Altice FL. 2015. Challenges to implementing opioid substitution therapy in Ukrainian prisons: personnel attitudes toward addiction, treatment, and people with HIV/AIDS. Drug Alcohol Depend. 148:47–55.
   PubMed Web of Science ®Google Scholar
• Priest KC, Englander H, McCarty D. 2020. "Now hospital leaders are paying attention": a qualitative study of internal and external factors influencing addiction consult services. J Subst Abuse Treat. 110:59–65.
   PubMed Web of Science ®Google Scholar
• Richard EL, Schalkoff CA, Piscalko HM, Brook DL, Sibley AL, Lancaster KE, Miller WC, Go VF. 2020. "You are not clean until you’re not on anything": perceptions of medication-assisted treatment in rural Appalachia. Int J Drug Policy. 85(2020):102704.
   PubMedGoogle Scholar
• Rudolph AE, Fernau DJ, Tobin KE, Latkin C. 2020. Individual and social network correlates of recent treatment for substance use disorders among persons who use drugs in Baltimore, MD (2014 – 2017. Drug Alcohol Depend. 217(2020):108278.
   PubMedGoogle Scholar
• Rundle SM, Cunningham JA, Hendershot CS. 2021. Implications of addiction diagnosis and addiction beliefs for public stigma: a cross-national experimental study. Drug Alcohol Rev. 40(5):842–846.
   PubMed Web of Science ®Google Scholar
• Simpson DD, Joe GW, Greener JM, Rowan-Szal GA. 2000. Modeling year 1 outcomes with treatment process and post-treatment social influences. Subst Use Misuse. 35(12–14):1911–1930.
   PubMed Web of Science ®Google Scholar
• Stone EM, Kennedy-Hendricks A, Barry CL, Bachhuber MA, McGinty EE. 2021. The role of stigma in U.S. primary care physicians’ treatment of opioid use disorder. Drug Alcohol Depend. 221:108627.
   PubMed Web of Science ®Google Scholar
• Tracy EM, Brown S. 2017. Social networks and social work practice. In Turner F, editor. Social work treatment: Interlocking theoretical approaches. 6th ed. New York: Oxford University Press.
   Google Scholar
• Walt L, Lupei M, Jason LA. 2021. Former substance abusing women, interpersonal relationships and social cognition: social comparison and sober housemate harmony predict women’s abstinence-specific efficacy. J Prev Interv Community. 50(2):137–150.
   PubMed Web of Science ®Google Scholar
• Warren JI, Stein JA, Grella CE. 2007. Role of social support and self-efficacy in treatment outcomes among clients with co-occurring disorders. Drug Alcohol Depend. 89(2–3):267–274.
   PubMed Web of Science ®Google Scholar
• Witte TH, Jaiswal J, Mumba MN, Mugoya GCT. 2021. Stigma surrounding the use of medically assisted treatment for opioid use disorder. Subst Use Misuse. 56(10):1467–1475.
   PubMed Web of Science ®Google Scholar
• Woo J, Bhalerao A, Bawor M, Bhatt M, Dennis B, Mouravska N, Zielinski L, Samaan Z. 2017. "Don’t judge a book by its cover": a qualitative study of methadone patients’ experiences of stigma. Subst Abuse. 11:1–12.
   Web of Science ®Google Scholar
• Woods JS, Joseph H. 2015. Stigma from the viewpoint of the patient. J Addict Dis. 34(2–3):238–247.
   PubMed Web of Science ®Google Scholar